RAC2 and cancer: Rac2-KO and Rac3-KO mice showed slightly increased survival in a CML and ALL background, respectively,101,102 suggesting a possible oncogenic role for these genes; further experimentation will be required to determine the functional significance of these cancer-associated mutations.